<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
The stock price of Biogen reached a 52-week high of $468 this June before a sell-off drove the stock price down over 40% to its current level of around $266. The stock decline was partly driven by pessimism surrounding the Aduhelm launch, as we have discussed in our updates further below.
...read full article on Forbes
